TABLE 2

Steady-state plasma and brain concentrations of sunitinib in wild-type, Mdr1a/b(−/−), Bcrp1(−/−), and Mdr1a/b(−/−)Bcrp1(−/−) mice after a constant intraperitoneal infusion of sunitinib at a rate of 30 µg/h for 48 hours (n = 4 each group)

Data presented as the mean ± S.D.

GenotypePlasma CssBrain CssBrain-to-Plasma Ratio
µg/mlµg/g
FVB wild type0.19 ± 0.160.09 ± 0.060.51 ± 0.26
Mdr1a/b(−/−)0.18 ± 0.150.39 ± 0.362.33 ± 0.56a
Bcrp1(−/−)0.19 ± 0.190.09 ± 0.040.73 ± 0.44
Mdr1a/b(−/−)Bcrp1(−/−)0.26 ± 0.094.46 ± 1.66a17.44 ± 5.08a
  • a P < 0.005 compared with wild type.